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Abstract Attenuated viruses have been isolated and
studied not only as a practical means of controlling virus
diseases but also to gain a molecular understanding of viral
virulence and cross protection. They have been isolated
from crop fields and generated through high/low tempera-
ture treatment or by mutagens such as nitrous acid and
ultraviolet irradiation. Some viruses have been beneficially
used in fields and evaluated for one or more decades.
Molecular genetic studies on attenuated viruses have
revealed that amino acid substitutions are located in rep-
licase and the movement protein in tobamovirus, protein 2b
for cucumovirus, and P1 and HC-Pro for potyvirus. In most
cases, with a few exceptions, symptom attenuation is
positively correlated with a reduced level of RNA silencing
suppression. Molecular mechanisms underlying virus
attenuation and cross protection and the rationale for
practical use of attenuated viruses for effective virus dis-
ease control are discussed.
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Introduction
Attenuated or mild virus strains have been used to protect
crops against severe strains of the same or related virus
species. This method of crop protection is based on the
phenomenon called cross protection/interference, which
was first reported by McKinney (1929), who showed that
tobacco plants infected with a yellow strain of Tobacco
mosaic virus (TMV) show resistance to a severe mosaic
strain of TMV. Salaman (1933) reported that tobacco
inoculated with a mild strain of Potato virus X (PVX) is
resistant to severe strains of PVX. Holmes (1934) isolated a
masked strain (M) of TMV from tomato stems that had
been incubated at 34.5C for 14 days after inoculation with
a severe strain and elicited some resistance in tobacco and
tomato against a severe strain. Since then, there have been
a number of reports on vegetables and fruit trees including
tomato, cucumber, cacao, papaya, and citrus (reviewed by
Gal-On and Shiboleth 2006).
More recently, transgenic plants with a viral sequence
have been proven to confer resistance to the virus from
which the transgene was derived or to related viruses (Prins
et al. 2008). One remarkable example is transgenic papaya;
with the coat protein (CP) gene of Papaya ringspot virus
(PRSV), it expresses extreme resistance to PRSV (Fuchs
and Gonsalves 2008), although the resistance mechanism
in this papaya appears to be CP-mediated. These papaya
fruits have been sold in US and Canadian markets.
The mechanism of resistance in these transgenic plants
has been interpreted by either of two distinct models:
protein-mediated or RNA-mediated mechanisms
(Baulcombe 1996). In the former model, pre-existing CP
affects the virus infection process, i.e., inhibition of
uncoating and replication as shown for TMV (Bendahmane
et al. 2007). In the latter, the resistance results from RNA
silencing by host plants (Ratcliff et al. 1999).
The phenomenon of RNA silencing has been thought to
play a pivotal role in defending eukaryotes against invasive
genes such as viruses, transposons and transgenes (Ding
and Voinnet 2007). To counteract this host defense
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mechanism, viruses have evolved a means of counter-
attacking host plants: virus encoded suppressor(s) of RNA
silencing (Be´clin et al. 1998; Brigneti et al. 1998; Kasschau
and Carrington 1998). It is generally accepted that viral
RNA silencing suppressors (VRSs) are more or less related
to viral pathogenicity because the VRS represses silencing,
that is, virus infection in host plants is more vigorous,
which may virtually result in more severe symptoms (Dı´az-
Pendo´n and Ding 2008).
In this review, the present status of attenuated virus
studies is described first in relation to a means of protecting
crops from viral diseases. Then the mechanism of viral
attenuation and cross protection is discussed with reference
to RNA silencing. Finally, some characteristics of attenu-
ated viruses that are needed for effective virus disease
control are discussed in light of the molecular under-
standing of attenuated viruses.
Selection, isolation and induction of attenuated viruses
The most commonly used attenuated virus strains have
been isolated from naturally occurring variants that cause
attenuated symptoms or by random or direct mutagenesis
of wild, severe strains using nitrous acid or ultraviolet
irradiation. Nitrous acid is a well-known mutagen that
deaminates cytosine and adenine to produce uracil and
hypoxanthine, respectively, and thus, induces transitional
mutations. UV irradiation causes the formation of pyrimi-
dine dimers in DNA as well as in RNA (Bre´geon and
Sarasin 2005) and likely induces any type of mutation,
including base changes and insertion/deletions.
Some attenuated viruses have been isolated after culti-
vation at higher (35C) or lower (15C) temperatures than
the optimal. The underlying mechanism of attenuated virus
generation after temperature treatment is not yet clear.
However, the concept of quasispecies supports that tem-
perature treatment would facilitate the selection of mutated
viruses from preexisting variation rather than that the
treatment induces the mutation of a virus genome. A
pseudorecombinant RNA virus is one choice for selecting
an attenuated virus by the exchange of a viral RNA seg-
ment with the corresponding RNA from an attenuated
strain in multisegmented viruses including Cucumber
mosaic virus (CMV). Some attenuated viruses (strains/
isolates) are listed in Table 1.
An attenuated strain of Tomato mosaic virus (ToMV),
L11A, has been in practical use for over 30 years to protect
tomato in greenhouses against severe strain infection
(Oshima 1981). Tomato cultivars carrying resistance genes
(Tm-1, Tm-2 and/or Tm-2a) have been developed, and the
frequency of pre-inoculation with the attenuated strain has
decreased. However, when a resistant variety is not avail-
able, an attenuated strain is still required. In Europe and
New Zealand, an attenuated strain of ToMV (MII-16),
isolated by treatment with nitrous acid, was once used
Table 1 Examples of attenuated viruses used for cross protection
Virus Strain or isolate (method) (country) Crop
CGMMV SH33bb,d,e (Japan) Muskmelon Motoyoshi and Nishiguchi (1988)
CMV S51a,f, S52a,f (China); KO3a,f, CM95a (Japan) Tomato, Tobacco, etc. Kosaka and Fukunishi (1997), Sayama et al. (1993),
Tien and Wu (1991)
CSSMV Mild strainsa (Ghana) Cacao Hughes and Ollennu (1994)
CTV HM55a, M-16Ab (Japan), mild strainsa (Brazil) Citrus Costa and Mu¨ller (1980), Ieki et al. (1997), Sasaki (1974)
PMMoV Pa18b, C-1421b (Japan) Pepper Goto et al. (1984), Nagai (1987)
PRSV HA5-1d (USA, Taiwan) Papaya Yeh and Gonsalves (1984)
SMV Ala15-M2c (Japan) Soybean Kosaka and Fukunishi (1993)
TMV Mb (USA) Tobacco Holmes (1934)
ToMV L11A
b (Japan), MII-16d
(Holland, UK, etc.), Kd (China)
Tomato Goto and Nemoto (1971), Rast (1975), Yang et al. (2002)
ZYMV ZY95c,d (Japan) Cucumber Kosaka and Fukunishi (1997)
CGMMV, Cucumber green mottle mosaic virus; CMV, Cucumber mosaic virus; CSSMV, Cocoa swollen shoot mosaic virus; CTV, Citrus
tristeza virus; PMMoV, Pepper mild mottle virus; PRSV, Papaya ringspot virus; SMV, Soybean mosaic virus; TMV, Tobacco mosaic virus;
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(Rast 1975). By the same method, an attenuated strain
(ToMV-K) was produced and has been used in China for
two decades (Yang et al. 2002). An attenuated strain
(SH33b) of Cucumber green mottle mosaic virus
(CGMMV) was isolated through nitrous acid and UV
irradiation and has been used for muskmelon in green-
houses in Japan (Motoyoshi and Nishiguchi 1988). Some
attenuated strains (Pa18 and C-1421) of Pepper mild mottle
virus (PMMoV) have been used in pepper fields (Goto
et al. 1984; Nagai 1987).
Tomato and tobacco diseases by CMV are also con-
trolled by attenuated strains in Japan and China (Sayama
et al. 1993; Tien and Wu 1991). In some cases, satellite
RNA was added to field isolates of CMV to attenuate
symptoms (Sayama et al. 1993). In Japan, this strategy has
been applied not only to tomato but also to cucumber,
petunia and Texas bluebell (Eustoma grandiflorum)
(Sayama 1996).
Soybean has been preventively inoculated with an
attenuated strain (Ala-15) of Soybean mosaic virus, which
was isolated from soybean plants incubated at a lower
temperature (15C) (Kosaka and Fukunishi 1993). An
attenuated strain (ZYMV-2002) of Zucchini yellow mosaic
virus (ZYMV) isolated through low temperature treatment
has also been applied to cucumber (Kosaka et al. 2006).
Papaya in Hawaii and Taiwan was tested for cross pro-
tection by an attenuated strain of PRSV (HA-21), showing
significant protection (Yeh et al. 1988). Some attenuated,
field-selected strains of Cacao swollen shoot virus (CSSV)
have been used for cross protection on cacao to prevent
severe damage from CSSV (Hughes and Ollennu 1994).
Side effects of preventive inoculation with attenuated
virus and monitoring attenuated viruses applied
to fields
The goal of preventive inoculation with an attenuated virus
is to protect crops from infection with severe strains. The
quantity and/or quality of the final harvested products are
significantly important, and they should have a similar
level of quality to virus-free control. In the case of CMV,
the content of vitamin C was higher in tomato inoculated
with attenuated CMV compared with that in virus-free
tomato (Sayama 1996). This result is an unexpected
advantage of using an attenuated virus.
In monitoring attenuated CMV in fields, necrotic spot, a
serious disease that manifests itself on the surface of the
fruits, was markedly reduced by application of the attenu-
ated CMV. The longer the attenuated virus was used, the
less frequent was disease occurrence, and there was no
serious damage for 10 years (Sayama et al. 2001). When an
attenuated strain of CGMMV was monitored in
greenhouses after serial use of the attenuated strain, no
substantial disease damage was found, implying that pre-
ventive inoculation reduces the chance of infection by a
severe strain and that the attenuated strain is inacti-
vated more effectively than the wild severe strain SH
(Anonymous 1988).
Molecular and biological characterization of attenuated
viruses
Tobamovirus
Attenuated virus genomes have been reported for several
tobamoviruses (Table 1; Fig. 1a). In L11A, 11 base substi-
tutions were located in the genome when compared with the
wild-type, severe strain L (Nishiguchi et al. 1985). Of those,
only three at amino acid (aa) positions 348, 760 and 896 in
the 130-kDa protein caused amino acid replacements. These
three amino acid replacements were compared with those in
L11, from which L11A was derived (Goto and Nemoto
1971). Only one of them, the change from cysteine (C) in
wild-type strains to tyrosine (Y) in attenuated strains at aa
position 348 (at nucleotide position 1117), was conserved
within these two attenuated virus strains (L11A and L11),
suggesting that the amino acid replacement at aa position
348 is important for virus attenuation (Nishiguchi et al.
1985). Kubota et al. (2003) later proved that the change of
C–Y at aa position 348 in the infectious L cDNA clone
rendered the mosaic symptom into an attenuated phenotype.
That mutated clone is referred to as TLJ. It was also found
to be the only nucleotide substitution between L11 and L
over the genome (Kubota et al. 2003). They also showed
that the wild-type 130-kDa protein had greater RNA
silencing suppressor activity than that of the attenuated
mutant TLJ, suggesting that the amino acid replacement
from C to Y at aa position 348 in the 130-kDa protein plays
an important role in reducing the RNA silencing suppres-
sion activity of the 130-kDa protein. More recently, Hag-
iwara-Komoda et al. (2008) reported that the 130-kDa
protein of ToMV was detected in both a soluble and a crude
membrane fraction. The latter contains the TOM1 protein,
which is required for multiplication of tobamoviruses in
Arabidopsis and tobacco (Asano et al. 2005; Yamanaka
et al. 2000). In the NtTOM1 (tobacco ortholog of TOM1)-
overexpressing transgenic tobacco plants, the level of the
130-kDa protein in the soluble fraction was reduced
because the overexpressed NtTOM1 recruited and anchored
the 130-kDa protein to membranes. The reduced level of the
soluble 130-kDa protein resulted in a reduction of RNA
silencing suppression. The propagation of both L and L11
were inhibited in this NtTOM1-overexpressing line,
implying that silencing suppression was apparently caused
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by the 130-kDa protein in the soluble fraction (Hagiwara-
Komoda et al. 2008). The molecular mechanism underlying
the silencing suppression by the tobamovirus 130-kDa
protein (replicase protein) (including the 122-kDa protein
of cr-TMV and the 126-kDa protein of TMV) is postulated
to prevent formation of the RNA-induced silencing com-
plex (RISC) after siRNA and miRNA syntheses (Csorba
et al. 2007; Ding et al. 2004; Kubota et al. 2003; Vogler
et al. 2007). The 130-kDa protein was found to bind to
double-stranded RNA (dsRNA) but not to single-stranded
CP
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Fig. 1 Location of amino acid substitutions among severe and
attenuated strains in tobamovirus, cucumovirus and potyvirus.
a Tobamovirus; b cucumovirus; c potyvirus (modified from Plisson
et al. 2003). Only amino acid substitutions are described on the
genome RNA. Three domains, methyltransferase, helicase and RNA
polymerase (RNA pol) are shown in the 180-kDa ORF (Koonin 1991;
Shintaku et al. 1996). MP and CP in a represent movement and coat
proteins, respectively. Dotted square in b represents arginine-rich
region in 2b protein (Goto et al. 2007). KITC, FRNK, IGN, CC/SC,
C344 and H417 in c represent domains (single letter of amino acid
and number of amino acids from N-terminal of HC-Pro) in HC-Pro
(Plisson et al. 2003). Asterisk shows CDNQLD domain, 12 amino
acids downstream from FRNK (Desbiez et al. 2010). PTGS
posttranscriptional gene silencing, VIGS virus-induced gene silencing.
Tobacco mosaic virus (TMV) M (Shintaku et al. 1996), TMV V-36
(Lewandowski and Dawson 1993), Tomato mosaic virus (ToMV-
L11A) (Nishiguchi et al. 1985), ToMV-K (Yang et al. 2002),
Cucumber green mottle mosaic virus (CGMMV)-SH33b (Tan et al.
1997), Pepper mild mottle virus (PMMoV)-Pa18 (Ichiki et al. 2005),
PMMoV-C1421 (Hagiwara et al. 2002), Cucumber mosaic virus
(CMV) 36R37 (Kobori et al. 2005), CMV CM95 (Goto et al. 2007),
Zucchini yellow mosaic virus (ZYMV)FINK (Shiboleth et al. 2007),
Papaya ringspot virus (PRSV) HA 5-1 (Chiang et al. 2007), Clover
yellow vein virus (ClYVV) MM(T27I-D193Y) (Yambao et al. 2008),
Bean yellow mosaic virus (BYMV) M11(pIbGSB) (Nakazono-
Nagaoka et al. 2009)
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RNA (ssRNA) (Hagiwara-Komoda et al. 2008). The
dsRNA-binding activity and RNA-dependent RNA poly-
merase activity of the 130-kDa protein in the membrane
fractions were not significantly different between L and
TLJ. However, the 130-kDa protein level in the soluble
fraction was reduced in the attenuated strain TLJ compared
with that in the wild-type L, implying that the binding
affinity of the attenuated 130-kDa protein to TOM1 or a
TOM1-containing membrane is higher than that of the wild-
type 130 kDa. Yamanaka et al. (2000) showed that the
helicase domain of the 130 kDa interacts with TOM1. The
mutation at aa position 348 of 130 kDa would alter the
structure of the helicase domain, increase the TOM1-
binding activity, and thus reduce the silencing suppressor
activity. Replication protein (122 kDa) of TMV-Cg was
found to disturb miRNA biogenesis by binding to small
RNA duplexes and changing the miRNA profiles (Kurihara
et al. 2007). It would be worth analyzing the difference in
the effects of the wild-type and attenuated 130-kDa repli-
cation proteins on the miRNA profiles.
Genomic characterization of an attenuated strain
(ToMV-K) (Yang et al. 2002) showed that two mutations
resulted in the production of UGA ochre and UAA opal
nonsense codons in the 126-kDa replicase and MP genes,
respectively, and that both mutations were shown to have
roles in symptom attenuation by producing the truncated
forms of the 126 kDa and MP. The attenuated phenotype of
a masked strain (M) of TMV (Table 1) has been charac-
terized in detail (Ding et al. 2004; Shintaku et al. 1996).
The TMV-M 126-kDa protein is reported to have a reduced
level of suppression of RNA silencing, while that of wild-
type TMV-U1 has higher suppressive activity. TMV-M has
eight amino acid substitutions in the 128-kDa protein. Each
substitution more or less affects symptom attenuation
(Ding et al. 2004).
An attenuated strain (SH33b) of CGMMV accumulated
approximately two-thirds of the parental strain SH in
melon plants. When the genome sequence of SH33b was
compared with that of the parental SH, 14 nucleotide
substitutions were found, plus three amino acid replace-
ments in the 129-kDa replicase and one in the CP (Tan
et al. 1997). Recently, the amino acid at position 479 (E–G)
has been suggested to play a role in RNA silencing sup-
pression activity (Chen et al. 2007).
The genomes of attenuated strains (Pa18 and C-1421) of
PMMoV were also compared with a severe strain,
PMMoV-J. As a result, valine (V) to alanine at aa position
649 in C-1421 and lysine to arginine (R) at aa position 549,
V to threonine at aa position 556 and serine to leucine in
Pa18 at aa position 760 were responsible for the attenuated
phenotype (Hagiwara et al. 2002; Ichiki et al. 2005). Viral
amplification of these mutants was 25% that of PMMoV-J.
An artificial mutant that carried these four amino acid
changes accumulated at a reduced level in infected plants
in comparison to PMMoV-J. The attenuated strain of
PMMoV engineered to contain the ToMV L11A type amino
acid mutation Y or D at aa 348 or 760 in the corresponding
position of the PMMoV 130-kDa protein was reported to
induce attenuated symptoms (Tsuda et al. 2007), suggest-
ing a common mechanism underlying symptom attenuation
among tobamoviruses. However, symptoms were attenu-
ated after infection with ToMV L that had a partial deletion
in the 30 noncoding region, but not in PMMoV with the
similar deletion (Tsuda et al. 2007). These results indicate
that mutations in the tobamovirus genome could have
distinct effects on gene function, even if their genomes are
highly conserved within the tobamoviruses.
Cucumovirus
CMV with a defective 2b protein caused mild symptoms
(Ding et al. 1995). CMV 2b inhibits AGO1-mediated
cleavage, implying that 2b is involved in biogenesis of the
host’s small RNA and affects symptom expression (Cillo
et al. 2009; Lewsey et al. 2009; Zhang et al. 2006). A severe
strain (CM95R) of CMV is a spontaneous mutant from an
attenuated strain (CM95), which was selected through a
series of local lesion isolations (Kosaka and Fukunishi
1997). The 2b protein encoded by CM95 differs in one
amino acid residue from that of CM95R (Goto et al. 2007)
(Fig. 1b). The 2b protein is known to be involved in virus
movement, virulence and posttranscriptional gene silencing
(PTGS) suppressor (Brigneti et al. 1998; Shi et al. 2002;
Soards et al. 2002). The 2b protein of CM95 showed weak
PTGS suppressor activity compared with that of CM95R
(unpublished results by Kobori and others in Goto et al.
2007) because of loss of the siRNA-binding property of 2b
of CM95. The point mutation in the 2b of CR95 is respon-
sible for binding to siRNA (Goto et al. 2007). Another
attenuated strain of CMV, 36R37, also had a different amino
acid substitution in 2b (Kobori et al. 2005) (Fig. 1b). Other
types of attenuated CMV strains harbor satellite RNA that
affects viral pathogenesis. An attenuating satellite RNA has
base substitutions and insertions in the region responsible
for the necrotic response and an insertion/deletion in other
regions (Sayama et al. 1993). The role of these base changes
in attenuating symptoms remains to be resolved.
Potyvirus
As listed in Table 1 and Fig. 1c, there are also reports of
attenuated potyviruses (Chiang et al. 2007; Lin et al. 2007b;
Yambao et al. 2008). When an attenuated strain (HA5-1) of
PRSV was compared with its parent strain HA using an
infectious cDNA clone, two amino acid substitutions
among three in the C-terminal region of P1 at aa positions
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309 and 481, and two of four in HC-Pro at aa positions 753
and 944 of HA5-1 appear to be critical in symptom atten-
uation in papaya (Chiang et al. 2007). In a comparison of
attenuated and severe strains of Clover yellow vein virus
(ClYVV), two amino acid substitutions in HC-Pro were
found to be responsible for symptom attenuation (Yambao
et al. 2008). Both mutations caused weaker RNA silencing
suppression than the wild type did, suggesting a correlation
between viral virulence and silencing suppression activity.
In ZYMV, one amino acid substitution from R to isoleucine
(ZYMVFINK)was found in HC-Pro at aa position 180 in the
FRNK motif of the attenuated strain AGII (Shiboleth et al.
2007). Other amino acid substitutions, phenylalanine to
leucine and glutamic acid to asparagine at aa positions 205
and 396, respectively, also affected symptom expression in
ZYMV (Lin et al. 2007b). A CDNQLD motif, located 12
amino acids downstream from the FRNK, also plays a role
in symptom severity (Desbiez et al. 2010). The attenuated
strain (GAC mutant) with two amino acid substitutions at aa
positions 180 and 396 did not affect RNA silencing sup-
pression, implying that symptom attenuation does not
always correlate with reduced RNA silencing suppression
(Lin et al. 2007b). Although this strain conferred complete
protection, the authors did not mention why. Because the
viral accumulation kinetics for the attenuated strain AG
were similar to those for the severe strain (Gal-On 2000).
This similarity might be responsible for the cross protection
ability. In studies with HC-Pro mutants of Tobacco etch
virus, hyposuppression of RNA silencing was correlated
with milder virulence, but hypersuppression did not corre-
late with stronger virulence than with the wild type (Torres-
Barcelo et al. 2008). HC-Pro is known as a multifunctional
protein: aphid transmissibility, viral cell-to-cell and long-
distance movement, viral amplification, symptom expres-
sion, synergism with other viruses, interaction with 20S
proteasome and cysteine type proteolysis, siRNA binding
and silencing suppressor including miR-guided cleavage of
target mRNAs (Maia et al. 1996; Plisson et al. 2003; Shi-
boleth et al. 2007). It is important to determine the structural
requirements for RNA silencing suppressor activity, virus
attenuation and cross protection.
Mechanisms of cross protection/interference
There are at least two mechanisms of cross protection:
protein mediated and nonprotein mediated (Baulcombe
1996). In the former, the CP of a protecting virus present in
cells may inhibit the uncoating step of an incoming virus.
This case was first reported by Sherwood and Fulton (1982)
who showed difficulty of infection by TMV in the yellow
region of leaves with mosaic symptoms. Abel et al. (1986)
showed delayed expression of symptoms after inoculation
with TMV in CP-expressing transgenic tobacco. When this
transgenic tobacco line was inoculated with TMV-RNA, no
resistance was detected, indicating the involvement of CP
in the uncoating step. There is a strong correlation between
CP accumulation and resistance (Abel et al. 1986; Loesch-
Fries et al. 1987) although the CP-mediated resistance
(CPMR) mechanism is not yet fully understood. More
recently, Bendahmane et al. (2007) suggested that there are
at least two mechanisms for CPMR against TMV: inter-
ference by CP in the disassembly of an infecting virus and
interference in the accumulation of viral replication com-
plexes by CP. They stress that the stability of CP–CP
interaction and the configuration of the quaternary structure
would be important for conferring resistance.
Because a viroid, which has neither protein-coding
capacity nor proteins (such as CP) that associate with the
genome, can also confer cross protection/interference,
there must be another mechanism or mechanisms than that
mediated by the CP. One such mechanism is gene silencing
by the host plant (Ratcliff et al. 1999). In addition to the
dsRNA produced during the replication of RNA viruses,
highly structured ssRNA is likely to trigger RNA silencing.
A recent report, however, implied that theoretical highly
structured RNA is not always a good substrate for small
RNA synthesis (Qi et al. 2009). When plants are infected
with a virus, RNA silencing will be induced in the host
plants, and an incoming second virus, which is similar to
the first virus, will be targeted for RNA degradation.
However, such is not the case in PVX CPMR: the inhibi-
tion of RNA silencing did not affect resistance (Bazzini
et al. 2006). Recently, Ziebell and Carr (2009) showed
cross protection between CMV strains in RNA-silencing-
impaired Arabidopsis mutants (dcl2, 3 and 4), suggesting
that DCL2, 3 and 4 are not required for cross protection in
this system. We cannot exclude the possibility, however, of
the involvement of other gene/copy in this system.
Ziebell and Carr (2009) also found that the two CMV
strains were mutually exclusive in the same infected
region. Although the same phenomena have also been
reported in Potyvirus and Cheravirus, the mechanism has
not yet been elucidated (Dietrich and Maiss 2003; Takah-
ashi et al. 2007). When these results are considered toge-
ther, cross protection/interference is not likely due to a
single mechanism but to multiple ones (Lin et al. 2007a).
Which mechanism plays a major role in the protection
would depend upon the particular system and conditions.
From molecular understanding to practical evaluation
of attenuated-virus-based control
Although several attenuated viruses have been used in
disease control in commercial fields, their practical use is
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still under debate. For example, Hull (2002) points out that
the use of a mild strain for protection is not recommended
as a general practice because of (1) some levels of yield
reduction, (2) risk as a virus reservoir for other crops, (3)
acquisition of virulence by mutation, (4) serious damage
from mixed infection with other viruses, (5) labor inten-
siveness and (6) risk of generating a new pathogenic virus
by recombination with other viruses. Although these con-
cerns are based on up-to-date knowledge from molecular
biological studies, they are not always true for all virus
systems. We emphasize that cross protection is still a
practical means of choice for plant virus disease control,
although it is recommended only under limited circum-
stances when no other protective means are available.
Nonetheless, the opposing view helps guide the devel-
opment of new attenuated viruses having better practical
properties. Addressing the issues raised by Hull (2002), we
propose the following properties as criteria for a good
attenuated virus strain for future development: (1) no
symptoms or very mild symptoms are induced in any of the
cultivated hosts, and the quality and quantity of the crop
products are not reduced, (2) most host tissues are fully
infected systemically, (3) they are highly stable genetically
without mutating into a severe phenotype, (4) there is no
vector transmission to other crops, (5) they protect against
a wide range of viruses and strains, (6) the quality/quantity
control of the inoculum and inoculations are easy and
inexpensive. Of these criteria, genetic stability would be
the most important factor for the practical use of attenuated
viruses. Schneider and Roossinck (2001) reported that the
diversity of RNA virus quasispecies depends on the host
species where the viruses replicated. Therefore, the genetic
stability of attenuated viruses should be examined in each
of the hosts to which they will be applied. Because cross
protection does not rely on harmful materials or chemicals
such as pesticides and fungicides, it is suitable for sus-
tainable agriculture, which is in high demand. Further
molecular study and understanding of cross protection/
interference should pave the way for broadening the
practical applications of attenuated viruses.
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